Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Tag: Eli Lilly and Company
PAREXEL and Eli Lilly to start a new clinical research program
PAREXEL, a life sciences consulting firm and contract research organization, announced a collaboration with Eli Lilly to launch a clinical research learning and development program in China.
Scientists unveiled a more effective approach for assessing drug response
Scientists from Eli Lilly, the Icahn School of Medicine and Sema4 released results from a study demonstrating that patient-derived cells offer a more effective approach for assessing drug response.
Eli Lilly licenses diabetes drug from Chugai Pharmaceutical
Chugai Pharmaceutical and Eli Lilly and Company announced they have entered into a license agreement for OWL833, Chugai’s oral non-peptidic GLP-1 receptor agonist.
Anima Biotech signs a drug discovery agreement with Lilly
Anima Biotech announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima's Translation Control Therapeutics platform.
Lilly and Sigilon Therapeutics join forces to develop diabetes treatment
Eli Lilly and Company and Sigilon Therapeutics announced a global collaboration to develop encapsulated cell therapies for the potential treatment of type 1 diabetes.
Eli Lilly obtained EU marketing authorization for anti-rheumatic drug
Eli Lilly and Company announced that the European Commission has granted marketing authorisation for Taltz, alone or in combination with methotrexate, for the treatment of active psoriatic arthritis
Curevac launches the construction of new GMP-compliant RNA production plant
CureVac AG announced the groundbreaking of its industrial-scale, GMP-compliant production facility at its headquarters in Tübingen, Germany
Lilly plans $72 million investment in insulin manufacturing
Eli Lilly and Company today announced plans to invest $72 million in an insulin manufacturing project at one of its facilities
Eli Lilly and CureVac set up a global immuno-oncology collaboration
Eli Lilly and CureVac have announced an immuno-oncology collaboration focused on the development and commercialization of potential cancer vaccine products
Lilly will collaborate with KeyBioscience AG on diabetes treatment
Eli Lilly and Company and KeyBioscience AG have agreed to a new collaboration focused on the development of Dual Amylin Calcitonin Receptor Agonists
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
V.P. Filatov Pharmaceutical Plant
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
Allele Biotech produced six iPSCs lines
Greek Pharma sustainability at stake
UK MHRA clarified cross-contamination Control Requirements
Subscribe to Newsletter!
© GMP news